• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD INSYTE AUTOGUARD BC SHIELDED IV CATHETER BLOOD CONTROL TECHNOLOGY; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD INSYTE AUTOGUARD BC SHIELDED IV CATHETER BLOOD CONTROL TECHNOLOGY; INTRAVASCULAR CATHETER Back to Search Results
Catalog Number 381023
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Death (1802)
Event Date 09/07/2020
Event Type  Death  
Manufacturer Narrative
Medical device expiration date: unknown.Device manufacture date: unknown.A device evaluation and/or device history review is anticipated, but is not complete.Upon completion, a supplemental report will be filed.(b)(4).
 
Event Description
It was reported that bd insyte¿ autoguard¿ bc shielded iv catheter blood control technology 22ga 1.00in was indwelled in a patient when they died.The following information was provided by the initial reporter: "bdj was asked by the customer to investigate whether the product was damaged or not.The details will be reported when additional information becomes available.On 16th sept 2020 new information received.(b)(6) the patient used this product was dead.Date of death is not reported.The customer asked us to perform investigation to see if the product is within specification.No other information is received as of today.21st sept, 2020 (b)(6).The sales rep received following information.Date of death: (b)(6) 2020.Sex: male.Age: 70s.Primary disease: gastric cancer.History: after endoscopic submucosal dissection is done, the patient suddenly went into cardiopulmonary arrest.Cardiopulmonary resuscitation was done though the patient was dead.".
 
Event Description
It was reported that bd insyte¿ autoguard¿ bc shielded iv catheter blood control technology 22ga 1.00in was indwelled in a patient when they died.The following information was provided by the initial reporter: "bdj was asked by the customer to investigate whether the product was damaged or not.The details will be reported when additional information becomes available.16th sept 2020 new information received.(b)(6).The patient used this product was dead.Date of death is not reported.The customer asked us to perform investigation to see if the product is within specification.No other information is received as of today.21st sept, 2020 (b)(6).The sales rep received following information.Date of death: (b)(6) 2020.Sex: male.Age: 70s.Primary disease: gastric cancer.History: after endoscopic submucosal dissection is done, the patient suddenly went into cardiopulmonary arrest.Cardiopulmonary resuscitation was done though the patient was dead.".
 
Manufacturer Narrative
H.6.Investigation: our quality engineer inspected the sample and photographs submitted for evaluation.Bd received one used catheter adapter assembly and six photos.Since no specific defect was reported, bd performed a thorough inspection of the unit and its components which involved investigating potential defects involving the adapter, catheter, septum, and actuator.Visual inspection of the device and photos were performed.It was observed that the actuator was pushed through the septum and dried media was present around the septum and base indicating that flow successfully occurred.Through microscopic examination of the catheter tubing, no damaged to the catheter tubing was observed.The catheter tip was inspected and determined to be acceptable.The functional test for leakage was conducted and no leakage was observed.Finally, the actuator and septum were inspected and no damage was observed.The returned unit provided for evaluation met and performed per the required manufacturing specifications.Bd was unable to identify any defects.Dhr was performed.No specific defect was identified by the customer and no defect was found during the investigation, therefore no comment can be made on whether process deviations or quality issues that occurred during manufacturing of the aforementioned lots were related to this defec.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD INSYTE AUTOGUARD BC SHIELDED IV CATHETER BLOOD CONTROL TECHNOLOGY
Type of Device
INTRAVASCULAR CATHETER
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
MDR Report Key10638787
MDR Text Key210162427
Report Number1710034-2020-00646
Device Sequence Number1
Product Code FOZ
Combination Product (y/n)N
PMA/PMN Number
K110443
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Type of Report Initial,Followup
Report Date 10/12/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Device Operator Other
Device Catalogue Number381023
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/01/2020
Initial Date Manufacturer Received 09/14/2020
Initial Date FDA Received10/06/2020
Supplement Dates Manufacturer Received09/14/2020
Supplement Dates FDA Received10/12/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Death;
-
-